Marginal-Zone Lymphomas

N Engl J Med. 2022 Feb 10;386(6):568-581. doi: 10.1056/NEJMra2102568.

Authors

Davide Rossi¹, Francesco Bertoni¹, Emanuele Zucca¹

Affiliation

¹ From the International Extranodal Lymphoma Study Group, Bellinzona; the Institute of Oncology Research, Bellinzona; the Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona; and the Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano - all in Switzerland.

PMID: 35139275
DOI: 10.1056/NEJMra2102568

No abstract available

Publication types

Review

MeSH terms

Diagnosis, Differential
Disease Progression
Humans
Lymphoma, B-Cell, Marginal Zone* / diagnosis
Lymphoma, B-Cell, Marginal Zone* / epidemiology
Lymphoma, B-Cell, Marginal Zone* / genetics
Lymphoma, B-Cell, Marginal Zone* / therapy
Mutation
Neoplasm Staging
Prognosis
Risk Factors
Survival Rate